Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Edwards Lifesciences Corp.

Share:
Related EW
3 Stocks Moving Big In Tuesday's After-Hours Session
Earnings Recap For February 2
Starbucks, Foot Locker Beat the Market Over Past Year (GuruFocus)

In a report published Friday, Jefferies & Company reiterated its Buy rating on Edwards Lifesciences Corp. (NYSE: EW), and raised its price target from $115.00 to $125.00.

Jefferies noted, “We published two physician surveys on transcatheter aortic valve replacement (TAVR), one of early adopters and the other of current non-users. Based on the results, which show strong and sustainable procedure growth, we are increasing our forecasts and target. We continue to rate EW shares Buy.”

Edwards Lifesciences Corp. closed on Thursday at $102.88.

Latest Ratings for EW

DateFirmActionFromTo
Jan 2016SunTrust Robinson HumphreyUpgradesNeutralBuy
Jan 2016Evercore ISI GroupInitiates Coverage onHold
Dec 2015Credit SuisseMaintainsOutperform

View More Analyst Ratings for EW
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (EW)

Get Benzinga's Newsletters